FDA Approved: AZASITE — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AZASITE (azithromycin monohydrate ophthalmic solution) submitted by Thea Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Blepharitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

SUPPL AP for AZASITE (AZITHROMYCIN MONOHYDRATE)